- Abstract:
-
It is unclear which maintenance treatment for bipolar disorder is superior in clinical practice. Randomized controlled head-to-head trials of available drugs either do not exist or are inconclusive. We aimed to compare rates of monotherapy treatment failure in individuals prescribed lithium, valproate, olanzapine or quetiapine by a population-based cohort study using electronic health records. 5,089 patients with bipolar disorder were prescribed lithium (N=1,505), valproate (N=1,173) olanzapi...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted manuscript
- Publisher:
- Wiley Publisher's website
- Journal:
- World Psychiatry Journal website
- Volume:
- 15
- Issue:
- 1
- Pages:
- 53-58
- Publication date:
- 2016-02-01
- DOI:
- ISSN:
-
1723-8617
- URN:
-
uuid:5756f42b-7968-45fd-8f53-fdad3120aa5f
- Source identifiers:
-
601565
- Local pid:
- pubs:601565
- Language:
- English
- Keywords:
- Copyright holder:
- World Psychiatric Association
- Copyright date:
- 2016
- Notes:
- © 2015 World Psychiatric Association. Published by Wiley. This is the accepted manuscript version of the article. The final version is available online from Wiley at: [10.1002/wps.20298]
Journal article
Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record